NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

What you say you’ve been right about is still all open for debate.

ALT-DC may be DCVAX but should the UCLA-NWBO relationship sour (if it hasn’t already?), UCLA will likely continue on with their own “next gen” ALT-DC. All the rest is still open for debate.

>>I have been right about a lot. I was right about ATL-DC being DCVax-L three years ago and till this day I still take paid shills to school in the topic. I am right in the ORR endpoints debate. I am right in my debunking of the trial design, endpoint, external control FUD garbage critique. I was right about Linda Powers not having build Advent as a private self enrichment project.